IAM Patent 1000 2022

Patents are essential business commodities and knowing how to obtain, enforce and monetise them has become mission critical. The IAM Patent 1000 has firmly established itself as the definitive ‘go-to’ resource for those seeking to identify world-class, private practice patent expertise.

China: Foreign

In the 14th Five Year Plan Notice on Intellectual Property, China released its aim to double its number of foreign patents by 2025. This ambitious goal has its limits – the state-funded patent subsidy programme can only boost the number, but not necessarily the total value, of intellectual assets overseas....

Read more

In the 14th Five Year Plan Notice on Intellectual Property, China released its aim to double its number of foreign patents by 2025. This ambitious goal has its limits – the state-funded patent subsidy programme can only boost the number, but not necessarily the total value, of intellectual assets overseas. The Chinese government recognised this, and in January 2021 it announced a plan to scrap all funding for patent applications. Hopefully, the future of the country’s IP landscape will gradually shift from sheer quantity to perceivable quality. As Chinese companies become more assertive in their global patent strategies and seek more ways to monetise their IP portfolios, there has been a discernible uptick of outbound patent work. Finally, the implementation of the drug patent linkage system in China last year has opened up a vast number of opportunities for generic drugs innovations and patent applications. Together with the regulation amendment of the China National IP Administration (CNIPA), which allows foreign patent agencies to set up representative offices in mainland China, 2022 is a very exciting and promising year for both domestic and foreign IP advisers.

Show less

Get unlimited access to all IAM content